Literature DB >> 11244527

Audit of pain management at home following tonsillectomy in children.

J J Homer1, J Swallow, P Semple.   

Abstract

The pain experienced at home and the burden this places on primary care resources is considerable following tonsillectomy in children. This was audited by postal questionnaire in 52 patients (36 responders). We found a significant proportion of patients experiencing moderately severe to severe pain and a high rate of consultation with general practitioners (50 per cent) for pain-related issues. These findings lead to changes in practice which included the provision of five days discharge medication (paracetamol/ibuprofen in non-asthmatics; paracetamol/dihydrocodeine in asthmatics) and improved written discharge advice. On re-auditing a year later in 100 patients (56 responders), we found reduced rates of consultation with general practitioners (27 per cent). However, the proportion of children experiencing moderately severe to severe pain was not reduced probably because most children were given the recommended analgesia during the first audit. We also found that paracetamol and ibuprofen was superior to paracetamol and dihydrocodeine for analgesia (p <0.05). Suggestions for further improvements are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244527     DOI: 10.1258/0022215011907208

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  9 in total

1.  The pediatric PRO-SELF©: pain control program: an effective educational program for parents caring for children at home following tonsillectomy.

Authors:  Kimberly A Sutters; Marilyn C Savedra; Christine Miaskowski
Journal:  J Spec Pediatr Nurs       Date:  2011-08-12       Impact factor: 1.260

2.  Efficacy of standard doses of Ibuprofen alone, alternating, and combined with acetaminophen for the treatment of febrile children.

Authors:  Ian M Paul; Sarah A Sturgis; Chengwu Yang; Linda Engle; Heidi Watts; Cheston M Berlin
Journal:  Clin Ther       Date:  2010-12       Impact factor: 3.393

3.  Parents' management of children's pain at home after surgery.

Authors:  Catherine Vincent; Maria Chiappetta; Abigail Beach; Carolyn Kiolbasa; Kelsey Latta; Rebekah Maloney; Linda Sue Van Roeyen
Journal:  J Spec Pediatr Nurs       Date:  2012-03-07       Impact factor: 1.260

4.  A randomized clinical trial of the efficacy of scheduled dosing of acetaminophen and hydrocodone for the management of postoperative pain in children after tonsillectomy.

Authors:  Kimberly A Sutters; Christine Miaskowski; Danielle Holdridge-Zeuner; Steven Waite; Steven M Paul; Marilyn C Savedra; Brent Lanier; Karla Mahoney
Journal:  Clin J Pain       Date:  2010-02       Impact factor: 3.442

5.  Pilot study to assess the safety of local lidocaine injections during endoscopic submucosal dissection for early gastric cancer.

Authors:  Shinsuke Kiriyama; Ichiro Oda; Fumiya Nishimoto; Yumi Mashimo; Hisatomo Ikehara; Takuji Gotoda
Journal:  Gastric Cancer       Date:  2009-11-05       Impact factor: 7.370

Review 6.  Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 7.  Ambulatory anesthetic care in children undergoing myringotomy and tube placement: current perspectives.

Authors:  Hal Robinson; Thomas Engelhardt
Journal:  Local Reg Anesth       Date:  2017-04-19

8.  The analgesic efficacy of preoperative oral Ibuprofen and acetaminophen in children undergoing adenotonsillectomy: a randomized clinical trial.

Authors:  Maziar Mahgoobifard; Yalda Mirmesdagh; Farsad Imani; Atabak Najafi; Masoomeh Nataj-Majd
Journal:  Anesth Pain Med       Date:  2014-02-28

9.  A Comparative Randomized Trial on the Optimal Timing of Dexamethasone for Pain Relief after Endoscopic Submucosal Dissection for Early Gastric Neoplasm.

Authors:  Jeung Hui Pyo; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim
Journal:  Gut Liver       Date:  2016-07-15       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.